These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7988301)

  • 1. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.
    Rydberg T; Jönsson A; Røder M; Melander A
    Diabetes Care; 1994 Sep; 17(9):1026-30. PubMed ID: 7988301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the kinetics of glyburide and its active metabolites in humans.
    Rydberg T; Jönsson A; Melander A
    J Clin Pharm Ther; 1995 Oct; 20(5):283-95. PubMed ID: 8576296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model.
    Choy S; Hénin E; van der Walt JS; Kjellsson MC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):1-10. PubMed ID: 23179858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function.
    Jönsson A; Rydberg T; Sterner G; Melander A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):429-35. PubMed ID: 9551701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man.
    Ligtenberg JJ; Venker CE; Sluiter WJ; Reitsma WD; Van Haeften TW
    Eur J Clin Invest; 1997 Aug; 27(8):685-9. PubMed ID: 9279533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
    El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4165-71. PubMed ID: 17698900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
    Balant L; Fabre J; Zahnd GR
    Eur J Clin Pharmacol; 1975; 8(1):63-9. PubMed ID: 823030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.
    Cozma LS; Luzio SD; Dunseath GJ; Langendorg KW; Pieber T; Owens DR
    Diabetes Care; 2002 Aug; 25(8):1271-6. PubMed ID: 12145220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide].
    Loutan L; Samimi H; Balant L; Favre H; Fabre J
    Schweiz Med Wochenschr; 1978 Nov; 108(45):1782-6. PubMed ID: 100879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.
    Haffner SM; Hanefeld M; Fischer S; Fuçker K; Leonhardt W
    Diabetes Care; 1997 Sep; 20(9):1430-4. PubMed ID: 9283792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral verapamil on glibenclamide stimulated insulin secretion.
    Semple CG; Omile C; Buchanan KD; Beastall GH; Paterson KR
    Br J Clin Pharmacol; 1986 Aug; 22(2):187-90. PubMed ID: 3092851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes.
    Jönsson A; Hallengren B; Rydberg T; Melander A
    Diabetes Obes Metab; 2001 Dec; 3(6):403-9. PubMed ID: 11903411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
    Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia.
    Bouazza N; Djerada Z; Gozalo C; Busiah K; Beltrand J; Berdugo M; Urien S; Treluyer JM; Polak M
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1373-1379. PubMed ID: 27561267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.